Drug Shortage Report for CERVARIX
Report ID | 45668 |
Drug Identification Number | 02342227 |
Brand name | CERVARIX |
Common or Proper name | Human Papillomavirus vaccine Types 16 and 18 |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN |
Strength(s) | 20MCG 20MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BM |
ATC description | VIRAL VACCINES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-04-09 |
Estimated end date | 2018-11-15 |
Actual end date | 2018-11-14 |
Shortage status | Resolved |
Updated date | 2018-11-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-04-13 | English | Compare |
v2 | 2018-04-13 | French | Compare |
v3 | 2018-07-06 | English | Compare |
v4 | 2018-07-06 | French | Compare |
v5 | 2018-07-11 | English | Compare |
v6 | 2018-07-11 | French | Compare |
v7 | 2018-10-10 | English | Compare |
v8 | 2018-10-10 | French | Compare |
v9 | 2018-11-14 | English | Compare |
v10 | 2018-11-14 | French | Compare |
v11 | 2018-11-15 | English | Compare |
Showing 1 to 11 of 11